IMU 1.41% 7.0¢ imugene limited

News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update

  1. 187,482 Posts.
    lightbulb Created with Sketch. 2754

    March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :

    • ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
    • IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
    • PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
    • NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
    • COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
    • TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS

    (([email protected];;))

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $512.3M
Open High Low Value Volume
7.2¢ 7.4¢ 7.0¢ $1.229M 17.36M

Buyers (Bids)

No. Vol. Price($)
7 707803 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 172396 5
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
7.1¢
  Change
-0.001 ( 1.25 %)
Open High Low Volume
7.2¢ 7.3¢ 7.0¢ 6411396
Last updated 15.59pm 15/05/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.